Study of NS-9 in Patients With Liver Metastases

Clinical trial NCT00094003 · COMPLETED

Trial details

NCT number: NCT00094003
Sponsor: NS Pharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Neoplasms Neoplasm Metastasis Local Neoplasm Recurrences

Start date: 2002-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.